Uniplan Investment Counsel, Inc. Ligand Pharmaceuticals Inc Transaction History
Uniplan Investment Counsel, Inc.
- $1 Billion
- Q4 2024
A detailed history of Uniplan Investment Counsel, Inc. transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Uniplan Investment Counsel, Inc. holds 68,155 shares of LGND stock, worth $8.33 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
68,155
Previous 53,104
28.34%
Holding current value
$8.33 Million
Previous $5.32 Million
37.28%
% of portfolio
0.73%
Previous 0.49%
Shares
4 transactions
Others Institutions Holding LGND
# of Institutions
276Shares Held
18.5MCall Options Held
30.8KPut Options Held
5.2K-
Black Rock Inc. New York, NY2.87MShares$351 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$255 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$124 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$108 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$90.9 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $2.06B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...